Infographic: CRISPR editing for treating Duchenne muscular dystrophy
Researchers are using CRISPR gene editing to restore function of the mutant protein that causes Duchenne muscular dystrophy, a genetic disease that causes muscle degeneration.
gene editing
In Vivo CRISPR Gene Editing for Genetic Disorders
LIVE October 25th, 2021 at 1:00 PM ET
Delivering CRISPR cargo in vivo to treat disease-causing DNA mutations
Delivering CRISPR cargo in vivo to treat disease-causing DNA mutations
CRISPR advances cardiovascular disease research
CRISPR gene editing directly and indirectly drives advances in cardiovascular disease therapeutic development.
Keolu Fox revises historical narratives with genome data
A native Hawaiian, anthropologist, and genome scientist, Keolu Fox investigates how mutations found in indigenous populations contribute to human health and emphasizes the importance of considering who benefits from research involving indigenous genomes.
On Target: Understanding Base Editors
LIVE July 28th, 2021 at 2:30 PM ET
In this webinar, experts will discuss cytosine and adenosine base-editors to introduce point mutations in DNA strands without creating a breakpoint, and opportunities and considerations for using them.
In this webinar, experts will discuss cytosine and adenosine base-editors to introduce point mutations in DNA strands without creating a breakpoint, and opportunities and considerations for using them.
Patent Docs: Patent interference parties provide evidence for priority
The arguments over "first to invent" and ownership of CRISPR tech continue
Duke University and eGenesis team up on xenotransplantation
Pair announces research collaboration leveraging eGenesis’ genome engineering and transgenic production capabilities to conduct in-vivo testing of pancreatic islet cell xenotransplants
